To compare PacBio long reads with MinION for de novo assembly of bacterial genomes what one should consider for library prep and assembly.
-
-
I am not sure what you are asking for. The PacBio option works: 1 library prep, sequence 1 SMRT-cell & assemble the data - you get a "finished" genome. If playing around with new technology is your goal, then the minion is worth considering. -
If the aim is to compare performance of two platforms. I would use the same sheared and size selected DNA from a bacteria with reference genome to prepare libraries for each platform. Then would sequence them to a certain Mb or Gb (can subsample reads to equal bases if one platform output is higher than the other) and use them for assembly and alignment. Metrics such as N50 (L50), contig number, proportion of data used for assembly, evenness of coverage, gaps and GC biases can be used for comparison.Last edited by nucacidhunter; 06-19-2015, 06:34 PM.Comment
-
Thanks for replies. I wonder if I can use similar approach for transcript isoform analysis.Comment
-
With mapping and assembly of DNA, to a known reference, it is relatively straightforward to determine which platform is better.
With isoform analysis, you're bringing in a huge number of additional variables; you won't know the correct answer, so you will have very little ability to evaluate which platform is doing a better job.Comment
-
I agree with Brian about isoform analysis potential issues. With current knowledge the best option is to access a well annotated fungal species with small genome or C. elegans (to keep sequencing cost down) and prepare full-length dscDNA from mRNA fraction using SMART technology and prepare libraries for both platforms. Transcripts sequences can be used for comparison against annotated regions and genome to compare the coverage of known isoforms and potential new isoform discovery of two platforms.Comment
-
Another option may be to get in touch with the Snyder lab and study the same transcriptomes used in their exploration of PacBio long-reads:
http://www.pnas.org/content/111/27/9869.abstractComment
-
Thank you very much everyone for your posts. I have much clearer idea to plan my Honours project.Comment
-
CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).
Despite this, “CRISPR helped turn genome editing from a specialized technique into...07-31-2026, 11:01 AM -
Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.
The systematic characterization of the human proteome has...07-20-2026, 11:48 AM -
Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
...07-09-2026, 11:10 AM
Comment